Stepien Thomas M sold $75K of AMPX

Stepien Thomas M (Chief Executive Officer) sold 4,375 shares of Amprius Technologies, Inc. (AMPX) at $17.19 on 2026-05-27.

Original reporting
SEC EDGAR · Stepien Thomas M
Published May 28, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 8:48 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AMPX
Neutral
medium confidence
Mentioned
$AMPX
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMPXNeutralLow
01

Why it matters

The newest fact is the CEO’s open-market sale details (shares, price, total value, and post-transaction holdings). This can influence short-term sentiment but does not provide new operational or financial guidance.

02

Market read

Traders may note the insider sale as a minor sentiment input, but there is no fundamental catalyst in the text to drive a durable repricing.

03

What to watch

The article does not state whether the sale was part of a 10b5-1 plan (it says no), nor does it provide context on total holdings, compensation, or future planned sales.

Relevance 3/10Novelty 5/10Timing: Form 4 filed 2026-05-28, covering sale dated 2026-05-27.

Background

The article is an SEC Form 4 insider transaction disclosure for Amprius Technologies, Inc. (AMPX).

Company-level read

Ticker impact

$AMPXNeutralMedium confidence
Context

Amprius Technologies CEO Stepien sold 4,375 shares in an open-market transaction at $17.1935 on 2026-05-27, per Form 4 filed 2026-05-28.

Expected impact

Low likelihood of a sustained price move solely from this Form 4; any impact is likely short-lived.

Evidence & confidence

The filing is a primary-source Form 4, but it is an open-market sale with no 10b5-1 plan stated and no accompanying fundamental catalyst in the text.

Market effects

No sector-wide implications are disclosed; this is company-specific insider transaction data.

None indicated.

None indicated.

Counterpoint

Insider sales can be driven by diversification, taxes, or pre-planned liquidity needs, so the signal may be overstated.

Key entities

  • Amprius Technologies, Inc.

    Subject of the Form 4 insider sale disclosure (AMPX).

  • Stepien Thomas M

    CEO and officer/director who sold shares via open-market sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AMPXMedAI 8/10

Amprius (AMPX) Q3 2026 Earnings Call Transcript

Amprius reported Q3 2026 revenue of $39.1M, up 83% YoY, raising its full-year target to $145M. The company introduced SiCore 500 cells for aviation and secured a $75M U.S. defense contract. Amprius expanded into maritime vehicles and partnered with U.S. manufacturers for NDAA-compliant production.

$AMPXMedAI 8/10

Amprius Technologies Q3 Earnings Call Highlights

Amprius reported a Q3 net loss of $3.5M, with adjusted EBITDA at -$1M. The company maintained its full-year gross margin forecast of 28% and expects Q4 sales of $43.3M. Amprius is expanding manufacturing to meet demand, with a $75M contract for a U.S. battery production line. It also introduced new products for aviation and deep-sea applications, ending Q3 with $60.7M in cash.

$AMPXHigh

Amprius Technologies falls 7% on third quarter earnings miss

Amprius Technologies (NYSE:AMPX) reported Q3 earnings missing estimates with a loss of $0.02 per share, though revenue of $39.1M beat expectations. Shares fell 7.7% after-hours. The company raised its full-year 2026 revenue outlook to $145M, above analyst forecasts. Gross profit rose 217% YoY to $10.5M, with gross margin improving to 27%. Amprius secured a $75M U.S. Department of War contract and introduced a new battery cell.

$AMPXMed

Amprius Technologies Reports Third Quarter 2026 Financial Results and Recent

Amprius Technologies, Inc. (AMPX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Amprius Technologies Reports Third Quarter 2026 Financial Results and Recent Business Highlights • Q3 2026 revenue increased 83% year-over-year to $39.1 million • Net loss of $3.5 million, a 10% year-over-year improvement • Increasing 2026 revenue outlook to $145 mil

$AMPXHigh

AMPX Stock Jumps As Defense Deals Supercharge Growth Story

Amprius Technologies Inc. (NYSE: AMPX) shares rose 8.38% on October 21, 2026, driven by U.S. Department of War funding and a partnership with Caminus for battery production. The company secured $75M in funding for a high-energy-density cell plant, with revenue growth but negative margins. Canaccord Genuity initiated coverage with a Buy rating and $14 price target.